Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-21 Sale |
2025-03-24 9:00 pm |
ATAI Life Sciences N.V. | ATAI | Kirpekar Sahil Chief Business Officer |
48,563 | $1.35 | $65,560 | 115,636 (Direct) |
View |
| 2025-03-21 Sale |
2025-03-24 9:00 pm |
ATAI Life Sciences N.V. | ATAI | Craig Kevin James Chief Medical Officer |
11,563 | $1.35 | $15,610 | 8,437 (Direct) |
View |
| 2025-03-21 Sale |
2025-03-24 9:00 pm |
ATAI Life Sciences N.V. | ATAI | Rao Srinivas See Remarks |
75,418 | $1.35 | $101,814 | 216,442 (Indirect Direct) |
View |
| 2025-03-21 Sale |
2025-03-24 9:00 pm |
ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Financial Officer |
33,545 | $1.35 | $45,286 | 140,045 (Direct) |
View |
| 2025-03-21 Sale |
2025-03-24 9:00 pm |
ATAI Life Sciences N.V. | ATAI | Short Glenn Frank Chief Scientific Officer |
13,161 | $1.35 | $17,767 | 42,333 (Direct) |
View |
| 2025-03-24 Purchase |
2025-03-24 5:00 pm |
ATAI Life Sciences N.V. | ATAI | Apeiron Investment Group Ltd. Angermayer Christian 10% Owner |
1,800,000 | $1.4 | $2,520,000 | 44,168,717 (Indirect) |
View |
| 2025-02-14 Purchase |
2025-02-19 6:00 pm |
ATAI Life Sciences N.V. | ATAI | Apeiron Investment Group Ltd. Angermayer Christian 10% Owner |
10,835,718 | $2.1 | $22,755,008 | 42,354,517 (Indirect) |
View |
| 2024-09-26 Sale |
2024-09-27 8:00 pm |
COMPASS Pathways plc | CMPS | ATAI Life Sciences N.V. ATAI Life Sciences AG 10% Owner |
2,660,000 | $6.05 | $16,093,000 | 6,905,774 (Indirect) |
View |
| 2024-05-16 Sale |
2024-05-20 5:30 pm |
ATAI Life Sciences N.V. | ATAI | Brand Florian See Remarks |
151,303 | $1.92 | $290,502 | 331,030 (Indirect Direct) |
View |
| 2024-04-02 Sale |
2024-04-04 6:11 pm |
ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Financial Officer |
27,410 | $1.85 | $50,709 | 73,590 (Direct) |
View |
| 2024-04-02 Sale |
2024-04-04 6:11 pm |
ATAI Life Sciences N.V. | ATAI | Rao Srinivas See Remarks |
61,640 | $1.85 | $114,034 | 116,860 (Indirect Direct) |
View |
| 2024-04-02 Sale |
2024-04-04 6:11 pm |
ATAI Life Sciences N.V. | ATAI | Kirpekar Sahil Chief Business Officer |
35,801 | $1.85 | $66,232 | 64,199 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-14 Exercise |
2025-03-19 7:29 pm |
N/A N/A |
ATAI Life Sciences N.V. | ATAI | Craig Kevin James Chief Medical Officer |
20,000 | $0 | 20,000 (Direct) |
View |
| 2025-03-14 Exercise |
2025-03-19 7:29 pm |
N/A N/A |
ATAI Life Sciences N.V. | ATAI | Short Glenn Frank Chief Scientific Officer |
32,500 | $0 | 55,494 (Direct) |
View |
| 2025-03-14 Exercise |
2025-03-19 7:29 pm |
N/A N/A |
ATAI Life Sciences N.V. | ATAI | Rao Srinivas See Remarks |
175,000 | $0 | 291,860 (Direct) |
View |
| 2025-03-14 Exercise |
2025-03-19 7:29 pm |
N/A N/A |
ATAI Life Sciences N.V. | ATAI | Kirpekar Sahil Chief Business Officer |
100,000 | $0 | 164,199 (Direct) |
View |
| 2025-03-14 Exercise |
2025-03-19 7:29 pm |
N/A N/A |
ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Financial Officer |
100,000 | $0 | 173,590 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-06 09:10 am |
N/A 2035-03-03 |
ATAI Life Sciences N.V. | ATAI | Short Glenn Frank Chief Scientific Officer |
757,915 | $0 | 757,915 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-06 09:06 am |
N/A 2035-03-03 |
ATAI Life Sciences N.V. | ATAI | Craig Kevin James Chief Medical Officer |
757,915 | $0 | 757,915 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-05 4:28 pm |
N/A 2035-03-03 |
ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Financial Officer |
757,915 | $0 | 757,915 (Direct) |
View |
| 2025-01-07 Option Award |
2025-01-10 4:15 pm |
N/A 2035-01-06 |
ATAI Life Sciences N.V. | ATAI | Rao Srinivas See Remarks |
2,340,000 | $0 | 2,340,000 (Direct) |
View |
Ownership |
2025-01-10 4:15 pm |
N/A N/A |
ATAI Life Sciences N.V. | ATAI | Short Glenn Frank Chief Scientific Officer |
0 | $0 | 1,611,626 (Direct) |
View |
Ownership |
2025-01-10 4:15 pm |
N/A 2032-01-03 |
ATAI Life Sciences N.V. | ATAI | Craig Kevin James Chief Medical Officer |
0 | $0 | 1,077,027 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-03 4:30 pm |
N/A 2035-01-01 |
ATAI Life Sciences N.V. | ATAI | Kochendoerfer Gerd Chief Operating Officer |
1,450,000 | $0 | 1,450,000 (Direct) |
View |
| 2024-10-04 Option Award |
2024-10-04 4:32 pm |
N/A 2030-08-20 |
ATAI Life Sciences N.V. | ATAI | Angermayer Christian Director 10% Owner |
624,000 | $0 | 624,000 (Direct) |
View |
| 2024-10-04 Option Award |
2024-10-04 4:30 pm |
N/A 2030-08-20 |
ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Financial Officer |
441,568 | $0 | 441,568 (Direct) |
View |
| 2024-10-04 Option Award |
2024-10-04 4:30 pm |
N/A 2030-08-20 |
ATAI Life Sciences N.V. | ATAI | Rao Srinivas See Remarks |
2,857,360 | $0 | 2,857,360 (Direct) |
View |
| 2024-10-04 Option Award |
2024-10-04 4:30 pm |
N/A 2030-08-20 |
ATAI Life Sciences N.V. | ATAI | Brand Florian See Remarks |
4,978,800 | $0 | 4,978,800 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 5:00 pm |
N/A 2034-06-13 |
ATAI Life Sciences N.V. | ATAI | Auerbach Michael Director |
103,000 | $0 | 103,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 5:00 pm |
N/A 2034-06-13 |
ATAI Life Sciences N.V. | ATAI | Angermayer Christian Director 10% Owner |
103,000 | $0 | 103,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 5:00 pm |
N/A 2034-06-13 |
ATAI Life Sciences N.V. | ATAI | Braunstein Scott Director |
206,000 | $0 | 206,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 5:00 pm |
N/A 2034-06-13 |
ATAI Life Sciences N.V. | ATAI | Smiley Andrea Heslin Director |
103,000 | $0 | 103,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 5:00 pm |
N/A 2034-06-13 |
ATAI Life Sciences N.V. | ATAI | Fischer Laurent Director |
206,000 | $0 | 206,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 5:00 pm |
N/A 2034-06-13 |
ATAI Life Sciences N.V. | ATAI | Kalali Amir H Director |
103,000 | $0 | 103,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 5:00 pm |
N/A 2034-06-13 |
ATAI Life Sciences N.V. | ATAI | JOHNSON SABRINA MARTUCCI Director |
103,000 | $0 | 103,000 (Direct) |
View |
| 2024-04-19 Other |
2024-05-03 4:05 pm |
2024-04-19 2026-02-01 |
IntelGenx Technologies Corp. | IGXT | ATAI Life Sciences N.V. ATAI Life Sciences AG 10% Owner |
1,000,000 | $0 | 10,500,000 (Indirect) |
View |
| 2024-04-15 Other |
2024-04-17 4:15 pm |
N/A N/A |
ATAI Life Sciences N.V. | ATAI | Apeiron Investment Group Ltd. Angermayer Christian 10% Owner |
295,900 | $0 | 147,950 (Indirect) |
View |